ClinicalTrials.gov
ClinicalTrials.gov Menu

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01051960
Recruitment Status : Completed
First Posted : January 20, 2010
Last Update Posted : March 7, 2018
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Rajan Saggar, University of California, Los Angeles